Research Options: Select below IPO Calendar	Week of Expected Pricing 11/1/2021 Company Name LIANBIO Proposed Ticker LIAN CUSIP 53000N108 Business Description A global, science-driven biopharmaceutical company dedicated to , developing and commercializing innovative medicines for patients with unmet, medical needs, with an initial focus on in-licensing assets for Greater China, and other Asian markets. Lead Underwriter BofA Securities, Inc, Goldman Sachs & Co. LLC, Jefferies LLC Co-Managers Raymond James and Associates, Inc. Initial Shares 2,03,12,500 Revised Initial Shares N/A Initial Price $15.00-$17.00 Revised Price N/A Final Price $16.00 Final Ticker LIAN
	© 2024 ICE Data Services. All rights reserved.